Screening for new MTHFR polymorphisms and NTD risk

Valerie B. O'Leary, James L. Mills, Anne Parle-McDermott, Faith Pangilinan, Anne M. Molloy, Christopher Cox, Andrea Weiler, Mary Conley, Peadar N. Kirke, John M. Scott, Lawrence C. Brody

Research output: Contribution to journalArticle

Abstract

The enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a key role in cellular folate metabolism. The A222V (677C->T) polymorphism is a confirmed neural tube defect (NTD) risk factor within Irish and other populations. To search for other unknown single nucleotide polymorphisms (SNPs) that might play a role in the etiology of NTDs, we examined the entire MTHFR coding region in healthy individuals (n = 100). SNPs were identified using sequencing and database analysis and allele frequencies were determined in our Irish population. We identified P39P (116C->T; T allele frequency 0.13) and previously reported R594Q (1793G->A; Q allele frequency 0.07). We screened a large ethnically homogeneous Irish NTD cohort (n>1,300) for P39P and R594Q. A possible association between NTD cases and P39P (P = 0.034) was found but this was not confirmed by transmission disequilibrium testing. R594Q also showed some evidence of a NTD case association (P = 0.07). Further analysis indicated these observations are due to linkage disequilibrium with A222V (677C->T), and therefore these new SNPs are unlikely to be independent risk factors for NTDs. As rates of NTDs differ between ethnic groups, we examined allele and genotype frequencies of P39P and R594Q within African-American and American-Caucasian populations. This is the first NTD association study of both R594Q and the novel P39P. The association with NTD risk reported for these SNPs is driven by the linkage disequilibrium with the A222V (677C->T) NTD risk factor.

Original languageEnglish (US)
Pages (from-to)99-106
Number of pages8
JournalAmerican Journal of Medical Genetics
Volume138 A
Issue number2
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Methylenetetrahydrofolate Reductase (NADPH2)
Neural Tube Defects
Gene Frequency
Single Nucleotide Polymorphism
Linkage Disequilibrium
Population
Folic Acid
Ethnic Groups
African Americans
Genotype
Databases
Enzymes

Keywords

  • 677C>T
  • MTHFR
  • NTD
  • P39P
  • R594Q
  • Sequencing
  • SNP

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

O'Leary, V. B., Mills, J. L., Parle-McDermott, A., Pangilinan, F., Molloy, A. M., Cox, C., ... Brody, L. C. (2005). Screening for new MTHFR polymorphisms and NTD risk. American Journal of Medical Genetics, 138 A(2), 99-106. https://doi.org/10.1002/ajmg.a.30846

Screening for new MTHFR polymorphisms and NTD risk. / O'Leary, Valerie B.; Mills, James L.; Parle-McDermott, Anne; Pangilinan, Faith; Molloy, Anne M.; Cox, Christopher; Weiler, Andrea; Conley, Mary; Kirke, Peadar N.; Scott, John M.; Brody, Lawrence C.

In: American Journal of Medical Genetics, Vol. 138 A, No. 2, 01.10.2005, p. 99-106.

Research output: Contribution to journalArticle

O'Leary, VB, Mills, JL, Parle-McDermott, A, Pangilinan, F, Molloy, AM, Cox, C, Weiler, A, Conley, M, Kirke, PN, Scott, JM & Brody, LC 2005, 'Screening for new MTHFR polymorphisms and NTD risk', American Journal of Medical Genetics, vol. 138 A, no. 2, pp. 99-106. https://doi.org/10.1002/ajmg.a.30846
O'Leary VB, Mills JL, Parle-McDermott A, Pangilinan F, Molloy AM, Cox C et al. Screening for new MTHFR polymorphisms and NTD risk. American Journal of Medical Genetics. 2005 Oct 1;138 A(2):99-106. https://doi.org/10.1002/ajmg.a.30846
O'Leary, Valerie B. ; Mills, James L. ; Parle-McDermott, Anne ; Pangilinan, Faith ; Molloy, Anne M. ; Cox, Christopher ; Weiler, Andrea ; Conley, Mary ; Kirke, Peadar N. ; Scott, John M. ; Brody, Lawrence C. / Screening for new MTHFR polymorphisms and NTD risk. In: American Journal of Medical Genetics. 2005 ; Vol. 138 A, No. 2. pp. 99-106.
@article{dfdecbc80ba4486383c98a9509553d43,
title = "Screening for new MTHFR polymorphisms and NTD risk",
abstract = "The enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a key role in cellular folate metabolism. The A222V (677C->T) polymorphism is a confirmed neural tube defect (NTD) risk factor within Irish and other populations. To search for other unknown single nucleotide polymorphisms (SNPs) that might play a role in the etiology of NTDs, we examined the entire MTHFR coding region in healthy individuals (n = 100). SNPs were identified using sequencing and database analysis and allele frequencies were determined in our Irish population. We identified P39P (116C->T; T allele frequency 0.13) and previously reported R594Q (1793G->A; Q allele frequency 0.07). We screened a large ethnically homogeneous Irish NTD cohort (n>1,300) for P39P and R594Q. A possible association between NTD cases and P39P (P = 0.034) was found but this was not confirmed by transmission disequilibrium testing. R594Q also showed some evidence of a NTD case association (P = 0.07). Further analysis indicated these observations are due to linkage disequilibrium with A222V (677C->T), and therefore these new SNPs are unlikely to be independent risk factors for NTDs. As rates of NTDs differ between ethnic groups, we examined allele and genotype frequencies of P39P and R594Q within African-American and American-Caucasian populations. This is the first NTD association study of both R594Q and the novel P39P. The association with NTD risk reported for these SNPs is driven by the linkage disequilibrium with the A222V (677C->T) NTD risk factor.",
keywords = "677C>T, MTHFR, NTD, P39P, R594Q, Sequencing, SNP",
author = "O'Leary, {Valerie B.} and Mills, {James L.} and Anne Parle-McDermott and Faith Pangilinan and Molloy, {Anne M.} and Christopher Cox and Andrea Weiler and Mary Conley and Kirke, {Peadar N.} and Scott, {John M.} and Brody, {Lawrence C.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1002/ajmg.a.30846",
language = "English (US)",
volume = "138 A",
pages = "99--106",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Screening for new MTHFR polymorphisms and NTD risk

AU - O'Leary, Valerie B.

AU - Mills, James L.

AU - Parle-McDermott, Anne

AU - Pangilinan, Faith

AU - Molloy, Anne M.

AU - Cox, Christopher

AU - Weiler, Andrea

AU - Conley, Mary

AU - Kirke, Peadar N.

AU - Scott, John M.

AU - Brody, Lawrence C.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - The enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a key role in cellular folate metabolism. The A222V (677C->T) polymorphism is a confirmed neural tube defect (NTD) risk factor within Irish and other populations. To search for other unknown single nucleotide polymorphisms (SNPs) that might play a role in the etiology of NTDs, we examined the entire MTHFR coding region in healthy individuals (n = 100). SNPs were identified using sequencing and database analysis and allele frequencies were determined in our Irish population. We identified P39P (116C->T; T allele frequency 0.13) and previously reported R594Q (1793G->A; Q allele frequency 0.07). We screened a large ethnically homogeneous Irish NTD cohort (n>1,300) for P39P and R594Q. A possible association between NTD cases and P39P (P = 0.034) was found but this was not confirmed by transmission disequilibrium testing. R594Q also showed some evidence of a NTD case association (P = 0.07). Further analysis indicated these observations are due to linkage disequilibrium with A222V (677C->T), and therefore these new SNPs are unlikely to be independent risk factors for NTDs. As rates of NTDs differ between ethnic groups, we examined allele and genotype frequencies of P39P and R594Q within African-American and American-Caucasian populations. This is the first NTD association study of both R594Q and the novel P39P. The association with NTD risk reported for these SNPs is driven by the linkage disequilibrium with the A222V (677C->T) NTD risk factor.

AB - The enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a key role in cellular folate metabolism. The A222V (677C->T) polymorphism is a confirmed neural tube defect (NTD) risk factor within Irish and other populations. To search for other unknown single nucleotide polymorphisms (SNPs) that might play a role in the etiology of NTDs, we examined the entire MTHFR coding region in healthy individuals (n = 100). SNPs were identified using sequencing and database analysis and allele frequencies were determined in our Irish population. We identified P39P (116C->T; T allele frequency 0.13) and previously reported R594Q (1793G->A; Q allele frequency 0.07). We screened a large ethnically homogeneous Irish NTD cohort (n>1,300) for P39P and R594Q. A possible association between NTD cases and P39P (P = 0.034) was found but this was not confirmed by transmission disequilibrium testing. R594Q also showed some evidence of a NTD case association (P = 0.07). Further analysis indicated these observations are due to linkage disequilibrium with A222V (677C->T), and therefore these new SNPs are unlikely to be independent risk factors for NTDs. As rates of NTDs differ between ethnic groups, we examined allele and genotype frequencies of P39P and R594Q within African-American and American-Caucasian populations. This is the first NTD association study of both R594Q and the novel P39P. The association with NTD risk reported for these SNPs is driven by the linkage disequilibrium with the A222V (677C->T) NTD risk factor.

KW - 677C>T

KW - MTHFR

KW - NTD

KW - P39P

KW - R594Q

KW - Sequencing

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=25644437881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25644437881&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.30846

DO - 10.1002/ajmg.a.30846

M3 - Article

VL - 138 A

SP - 99

EP - 106

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 2

ER -